IDHIFAPRO.COM: Keyword Density Checker

Total words: 4960 | 2-word phrases: 1270 | 3-word phrases: 1459 | 4-word phrases: 1537

PAGE INFO

Title	Try to keep the title under 60 characters (60 characters) IDHIFA® (enasidenib) For Relapsed/Refractory AML \| For HCPs
Description	Try to keep the meta description between 50 - 160 characters (195 characters) Discover IDHIFA® (enasidenib), an IDH2 inhibitor for relapsed/refractory acute myeloid leukemia (AML) with an IDH2 mutation. See Safety Information and Boxed WARNING on differentiation syndrome.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (43 characters) START WITH IDHIFA® AND STAY WITH IDHIFA®*

#	Keyword	Frequency	Density
1	oatp1b1 oatp1b3 and bcrp	12	0.78%
2	concomitant use of idhifa	12	0.78%
3	reactions related to the	12	0.78%
4	inhibitor concomitant use of	9	0.59%
5	changes may lead to	9	0.59%
6	concentration changes may lead	9	0.59%
7	patients treated with idhifa	9	0.59%
8	the risk of adverse	9	0.59%
9	increase the risk of	9	0.59%
10	for acute myeloid leukemia	7	0.46%
11	for acute myeloid leukemia?	7	0.46%
12	of adverse reactions related	6	0.39%
13	adverse reactions related to	6	0.39%
14	concomitant use with idhifa	6	0.39%
15	use with idhifa unless	6	0.39%
16	reactions related to these	6	0.39%
17	with idhifa unless otherwise	6	0.39%
18	idhifa unless otherwise recommended	6	0.39%
19	unless otherwise recommended in	6	0.39%
20	acute myeloid leukemia n	6	0.39%
21	otherwise recommended in the	6	0.39%
22	and hemodynamic monitoring until	6	0.39%
23	related to the substrates	6	0.39%
24	fatal if not treated	6	0.39%
25	avoid concomitant use with	6	0.39%
26	transporter inhibitor concomitant use	6	0.39%
27	differentiation syndrome is suspected	6	0.39%
28	related to these substrates	6	0.39%
29	oatp1b3 and bcrp substrates	6	0.39%
30	risk of adverse reactions	6	0.39%
31	increases the exposure of	6	0.39%
32	if differentiation syndrome is	6	0.39%
33	regarding their content use	5	0.33%
34	responsibility for their application	5	0.33%
35	warranties of any kind	5	0.33%
36	no warranties of any	5	0.33%
37	any responsibility for their	5	0.33%
38	kind whatsoever regarding their	5	0.33%
39	whatsoever regarding their content	5	0.33%
40	disclaims any responsibility for	5	0.33%

#	URL	Whois	Check